Objective: Few studies have evaluated factors that influence menstrual cycle length (MCL) during the menopausal transition (MT), a life stage during which very long cycles become more likely to occur. The objective of this article was to assess how body mass index and race/ethnicityVfactors associated with MCL in young womenV influence MCL during the MT.
T he Stages of Reproductive Aging Workshop + 10 updated the criteria for staging reproductive age and clarified the menstrual bleeding criteria for early and late menopausal transition (MT). 1 However, data evaluating factors associated with population differences in menstrual cycle characteristics during this reproductive life stage are limited. Prior studies of younger women have documented that menstrual cycle length (MCL) is influenced by race/ethnicity 2<4 and body mass index (BMI). 4<8 BMI also influences the levels of, and trajectories of changes in, follicle-stimulating hormone (FSH) and estradiol during the MT. 9 The few extant menstrual calendar studies documenting women's menstrual experiences during the MTVwith one exceptionVincluded only white women. 10 The purpose of the present study was to assess the relationships of race/ethnicity and BMI with MCL among a multiracial/multiethnic cohort of midlife women in the Study of Women's Health Across the Nation (SWAN). We used quantile regression to evaluate the pattern of MCL during the MT given the increased frequency of very long cycles. Linear regression is often used to examine mean MCL; however, an assumption of this modeling technique is that MCLs are normally distributed. However, the distribution of MCLs in perimenopausal women is right-skewed 11 such that the median is more informative about central tendency than is the mean. Quantile regression allows examination of factors that influence the median and other quantiles of MCL distribution. Furthermore, quantile regression allows us to identify factors that influence the median independently of factors that influence other sections of the distribution, 12 including the important right tail. Another benefit of quantile regression is that coefficients are interpreted similarly to linear regression, with between-group differences quantified in days providing more clinically useful information than odds ratios estimated from a logistic regression model.
METHODS

Study design and population
This analysis included women from three SWAN sites: southeastern Michigan, Los Angeles, and northern California. Although participants at all seven sites filled out menstrual calendars, women at these three study sites participated in a more comprehensive menstrual calendar substudy, which included additional end-of-the-month questions on current smoking and physical activity. The design of the main cohort study has been previously described. 13 Briefly, after a crosssectional screening survey to assess eligibility, 1,498 women from the three substudy sites were enrolled into the cohort study at these three sites. Cohort eligibility criteria included the following: aged 42 to 52 years; self-designation as a member of a targeted racial/ethnic group; residence in the geographic area of one of the three clinic sites; ability to speak English, Cantonese, or Japanese; ability to give verbal consent; an intact uterus; at least one menstrual period; no use of reproductive hormones in the previous 3 months; and not pregnant or lactating. Each site recruited white women and women from one specified minority group (African Americans in southeastern Michigan, Japanese in Los Angeles, and Chinese in northern California). The Institutional Review Board at each study site approved the protocol, and all participants provided a written informed consent form.
SWAN began enrollment in 1996, and annual follow-up visits have been conducted since then. Each visit consisted of interviewer-administered and self-administered questionnaires on a broad range of topics, including menstrual characteristics, sociodemographic characteristics, lifestyle, and medical history. Participants underwent physical assessments, which included a blood draw and measurement of height and weight.
A self-administered menstrual calendar component began in 1996 and continued through 2006, corresponding to the 10th annual follow-up visit. Participants filled out menstrual calendars daily to capture days when any spotting or bleeding occurred. On the last day of the month, women indicated if no bleeding occurred and answered questions about hormone use, gynecological procedures that could affect bleeding, cigarette use, and physical exercise. Women were asked to maintain the monthly calendar for 2 years after they last bled.
The sequence of women's MCLs was assessed. MCL was calculated using World Health Organization bleeding definitions 14 adapted by the ReSTAGE Collaboration for application to perimenopausal women. 15 A menstrual cycle consists of a bleeding episode and a subsequent bleed-free interval of at least 3 days. Onset of early MT was defined using Stages of Reproductive Aging Workshop + 10 definitions. 1 It is defined as the onset of a persistent difference of at least 7 days in the length of consecutive menstrual cycles. Persistence is defined as a reoccurrence within the next 10 observed cycles. The onset of early MT is defined by the date of the start of the menstrual cycle in the first pair of cycles that differ in length by 7 days. The final menstrual period (FMP) is defined as the first day of the bleeding episode followed by at least 12 months of amenorrhea. To identify where in the MT a menstrual cycle occurred, we used two definitions of time: time since the MT onset and time until the FMP.
Hormone use, including menopausal hormone therapy, oral contraceptives, or chemotherapy, was assessed monthly. For months with missing hormone information, menstrual cycles were coded as untreated if a woman never reported hormone therapy use in the study, if the menstrual cycle occurred before the first report of hormone therapy use, or if the menstrual cycle occurred in a year where no hormone therapy use was reported in the monthly calendars or annual interview.
At each annual visit, height was measured without shoes using either a metric folding wooden ruler, a measuring tape, or a fixed stadiometer. Weight was measured without shoes and in light indoor clothing using a portable digital scale or a digital or balance beam. For each menstrual cycle, weight was linearly interpolated between the last annual visit and the next annual visit. BMI, calculated as weight in kilograms divided by height in meters squared, was categorized as underweight (G18.5 kg/m 2 ), normal weight (18.5-24.9 kg/m 2 ), overweight (25.0-29.9 kg/m 2 ), or obese (Q30.0 kg/m 2 ).
At each annual interview, women were asked whether they had been diagnosed with uterine fibroids or diabetes since the last visit or were taking medications for diabetes. Serum glucose levels were also measured at baseline and annual visits 1 and 3 to 7. A woman was considered to have diabetes if she indicated that she was diagnosed with diabetes, was taking diabetes medication, or had a fasting serum glucose level of 126 mg/dL or higher. For each of these two medical conditions, 6 months was subtracted from the annual visit date when a woman first indicated that she had the condition, and all menstrual cycles on or after this date were considered to have the condition.
Women were asked whether they smoked at least one cigarette a day or a total of 30 cigarettes in the last month, and positive responses were considered as current cigarette use for that month. If a woman never indicated that she was a smoker, all her menstrual cycles were considered nonsmoking. Women were asked if they participated in moderate to vigorous physical activity, the average number of times a week they participated, and the average number of minutes they participated each time. Average total hours of physical activity per week was calculated for each month. For menstrual cycles that covered more than 1 month, the highest average total hours of physical activity per week was used.
Race/ethnicity was self-defined and categorized as African American, Chinese or Chinese American, Japanese or Japanese American, or white. Highest education attained (high school graduate/GED or less than high school vs at least some college) and marital status (single, married, or separated, widowed, or divorced) were assessed at baseline. Economic strain was assessed at baseline with the question BHow hard is it to pay for basics?[ and was categorized as very hard, somewhat hard, or not hard. Prior use of female hormones (yes/no), which did not include oral contraceptives, was also assessed at baseline.
Statistical analysis
Of the 1,498 women who were enrolled, 1,320 (88.2%) women who had at least one untreated menstrual cycle with menstrual cycle level covariate information available were included in this analysis. Menstrual cycles were excluded if women were using hormones, if hormone use could not be ruled out, or if the menstrual cycle was the first cycle after hormone use. Women were censored at the time of hysterectomy, bilateral oophorectomy, or chemotherapy. Pregnancy and postpregnancy cycles were excluded, as were cycles with missing covariate information. Baseline demographics were compared for women included and excluded in the analyses. Pearson's W 2 test or Fisher's exact test and Student's t test were calculated as appropriate.
To examine how race/ethnicity, BMI, and other covariates influenced central tendency and variance of cycle length, we used quantile regression to model MCL at the 25th, 50th, 75th, and 90th percentiles. Quantile regression coefficients are interpreted similarly to linear regression coefficients of a linear regression. For example, the coefficients of a categorical predictor represent the difference in MCL in days for the relevant percentile between one category and the reference group, adjusted for all other covariates in the model. To better reflect standard error in our repeated-measures data, we conducted bootstrap sampling with 500 repetitions to construct 95% CIs. To handle within-woman correlation, we based bootstrap sampling on samples of women with all their eligible menstrual cycles included.
Two sets of quantile regression models were evaluated. First, we included 963 women with 37,288 cycles in whom we observed the start of the MT during the calendar substudy and examined factors associated with cycle length after the onset of the MT, indexing the time covariate to the start of the MT. In addition to race/ethnicity and BMI, we evaluated as covariates factors known to be associated with MCL in younger women. Covariates were included in the final models if we had evidence of an adjusted association with the 90th percentile, using the same model for each of the four percentiles of interest. Time since the start of the MT was added to the multivariate model using a natural cubic spline that contained knots at 2, 3, 4, 5, and 6 years. Statistical interaction between time since the start of the MT and other covariates was examined graphically.
The second set of models included 431 women with 18,305 cycles who had an FMP in the menstrual calendar data. To compare the FMP-adjusted models with the start of the MTadjusted models, we included similar covariates in both sets of models. Time until the FMP was added to the models using a natural cubic spline, with knots at j5, j4, j3, and j2 years and j1 year until the FMP. There were 356 women who had both the start of the MT observed and their FMP. Therefore, these women were included in both sets of models. To examine the association with study site, we ran multivariate models among white women with study site (instead of race/ ethnicity) as variable.
Baseline demographics were analyzed using SAS version 9.2 (SAS Institute, Cary, NC). Quantile regression was conducted using the quantreg package in R 2.13.1. 12
RESULTS
Of the 1,320 eligible women, 963 (73.0%) had onset of early MT, and 431 (32.7%) had their FMP identified in the menstrual calendars. In addition, 19 (1.4%) had had hysterectomy, 233 (17.7%) began using hormones and had no further untreated menstrual cycles observed, and 637 (48.3%) withdrew from the study before their FMP was identified. In 356 women, we observed both onset of early MT and their FMP in the calendar. African Americans comprised a higher percentage of women in whom we did not observe onset of early MT (30.0%) than of women in whom we did (13.4%). They also comprised a higher percentage of women in whom we did not observe the FMP (22.1%) compared with women in whom we did (9.3; Table 1 ).
Estimated MCL and 95% CI by time since the start of the MT are presented in Figure 1 for women who were white, were normal-weight or underweight, were aged younger than 46.25 years at the start of the MT, did not smoke, had at least some postYhigh school education, and had no moderate or physical activity during the average week. At approximately 2 years after the start of the MT, the MCL distribution began to widen, as seen by increases at the 75th and 90th percentiles. From 2 to 8 years after early MT, MCLs at the 90th percentile increased sharply. At approximately 7.5 years after the start of the MT, the variance of estimated MCL increased for each of the four percentiles, suggesting greater variability of MCL as women approached the FMP.
Multivariable quantile regression models for the 25th, 50th, 75th, and 90th percentiles of MCLs since the start of the MT are given in Table 2 . Associations were adjusted for all factors listed in the table and for time since the start of the MT. Quantile regression models are interpreted similarly to linear regression models. For example, the intercept for the 75th percentile (27.06 d) was the estimated MCL at the start of the MT for women in the reference category (women who were white, were normal-weight or underweight, were aged younger than 46.25 years at the start of the MT, did not smoke, had at least some postYhigh school education, and had no moderate or physical activity during the average week). The adjusted difference in MCL at the 75th percentile among women who were older at the start of the MT (946.25 y) was 3.01 days. The adjusted difference in MCL at the 75th percentile was 2.15 days longer for obese women, 1.56 days longer for smokers, and 1.27 days longer for women with only high school education or less. Notably, women who were older at the start of the MT (946.25 y) had longer cycle lengths at the 50th, 75th, and 90th percentiles compared with women who started the MT at a younger age. Chinese and Japanese women had longer MCLs (by 0.82-5.69 d) at all percentiles than white women. Overweight women had longer MCLs than normal-weight or underweight women at the 25th and 50th percentiles, and obese women had longer MCLs (by 1.45-4.94 d) than normal-weight or underweight women at all percentiles. Current smoking and having only high school education or less were associated with longer MCLs at the 75th and 90th percentiles. Hours of moderate or vigorous physical activity per week was associated with longer MCLs at only the 90th percentile. When added to the multivariable model, diabetes was associated with longer MCL only at the 50th percentile (0.70 d; 95% CI, 0.03 to 1.36). Uterine fibroids or previous hormone use during the study were not associated with MCL. We found no evidence of statistical interaction between time since the start of the MT and other covariates. Among white women, study site was not associated with MCL when entered into the multivariate model.
Estimated MCL and 95% CI by time until the FMP are shown in Figure 2 for women who were white, were normalweight or underweight, did not smoke, had at least some postYhigh school education, and had no moderate or physical activity during the average week. When observed from this time perspective, at approximately 7.5 years before the FMP, the distribution of MCLs began to increase, as shown by the increase in the 90th percentile. The steepest increase in MCL was seen between 4 and 1.5 years before the FMP. In the last 2 years before the FMP, the variance of estimated MCL increased for each of the four percentiles.
Relationships between factors of interest and MCL in the models for time until the FMP (Table 3) were similar to those observed in the models for time since the start of the MT. However, African-American women had longer MCLs than white women at the 50th and 75th percentiles. Neither current smoking nor education was associated with any of the percentiles. Again, no statistical interactions were observed between time until the FMP and other covariates. Among white women, women at Oakland had longer MCLs at the 25th 
DISCUSSION
This work is one of the first studies to assess whether demographic, lifestyle, and medical factors identified as influencing menstrual characteristics in adolescent and young adult women also influence MCL (particularly the length of the long cycles characteristic of this life stage) as women transition through menopause. Quantile regression facilitated our understanding of how race/ethnicity and BMI influenced both the median length of menstrual cycles and the length of cycles at the tail of the distribution. Notably, women who started the transition at older ages experienced consistently longer cycles. Chinese and Japanese women had consistently longer MCLs across the distribution of MCLs compared with white women, as did obese women compared with normal-weight women. Increased moderate to vigorous physical activity lengthened the menstrual cycle only at the right tail of the distribution, which is only the length of the longest cycles. Current cigarette smoking also tended to increase MCL at the right tail only.
Increases in MCL, as women progressed through the MT, were mostly limited to the upper percentiles, with the median unaffected until about 3 years before the FMP, when a small increase was seen. MCL at the right tail began to increase approximately 2 years after the start of the MT or 7 years before the FMP. In a prior analysis from the same cohort, 9 FSH levels indexed to the FMP rose during a similar timeframe. In an analysis of TREMIN data, a historic cohort with menstrual calendars maintained across the entire life span, the average MCL began to increase rapidly starting at 4 years before the FMP. 16 In the present study, we found that menstrual cycles became highly variable in the 2 years before the FMP, as seen by the increase in 95% CI across all four percentiles. The Melbourne Midlife Women's Health Project reported a similar result; MCL variability was highest during the last 17 menstrual cycles before the FMP, 17 as was the rate of FSH increase in SWAN. 9 Available evidence suggests that menstrual cycle characteristics differ by race/ethnicity. The Semiconductor Health Study reported that Asian women had MCLs that were approximately 2 days longer than those of white women. 3 A similar result was reported by the Women's Reproductive Health Study. 4 In the present study, Chinese and Japanese women had longer MCLs than white women, suggesting that these East Asian women may have longer MCLs throughout their reproductive life span. FIG. 1. Estimated cycle length and 95% CIs by time since the start of transition from multivariable quantile regressions for four percentiles (25th, 50th, 75th, and 90th). Natural cubic spline of time since the start of transition contained five knots at 2, 3, 4, 5, and 6 years. Estimated cycle lengths are for women who were white, were normal-weight or underweight, were aged younger than 46.25 years at the start of transition, did not smoke, had at least some postYhigh school education, and did not have any moderate or physical activity during the average week. Sample size decreases as time since the start of transition increases.
We found that obese women had longer MCLs than normalweight women across the distribution of MCLs, consistent with prior studies. In the baseline analysis of the SWAN daily hormone study, which used information from one menstrual cycle at the first follow-up visit, a higher percentage of women who were overweight or obese had an MCL of 33 days or more compared with normal-weight women. 18 Higher BMI has been associated with longer MCLs in women aged 17 to 19 years 5 and in women aged 20 to 40 years. 4,6<8 However, not all studies reported an association between MCL and BMI. 3, 19, 20 Obesity has been associated with circulating levels of FSH and estradiol in SWAN and in other studies of the MT. 9, 21 Several studies have demonstrated an association between physical activity and longer MCL. In athletes, less frequent menstrual cycles have been reported. 22, 23 Among adolescent girls 2 and young adult women, 5, 24, 25 physical activity increased mean MCL. We found that physical activity was associated with longer MCL at the right tail of the distribution, but not at the median.
Current cigarette smoking was associated with longer MCL at the upper percentiles in the model indexed to the onset of early MT, but not in the model indexed to the FMP. Prior studies examining cigarette use have not found an association with MCL 3,24<26 or have found that smoking is associated with shorter MCLs. 6, 7, 27 Smokers have earlier age at menopause than nonsmokers 28<34 and a shorter duration of perimenopause 35 ; thus, the longer cycles exhibited by smokers when indexed to the start of the MT may reflect the shorter duration of perimenopause in these women.
This study had some important limitations. The mean age of women eligible for SWAN was 45.7 years; it is possible that, for some women, the onset of the MT occurred before enrollment into the study. Age-eligible women who were in the late stage of the MT or who had already experienced their FMP were excluded. Women with younger ages at FMP may have different menstrual cycle characteristics. 36 In the crosssectional study from which the SWAN cohort was selected, African-American women were more likely to have had had hysterectomy and were thus less likely to be enrolled into the cohort study. 28 In the current analysis, African-American women were less likely to have had had their FMP observed; thus, observed associations in the model for time until the FMP may have been caused by differential loss to follow-up.
CONCLUSIONS
Increases in MCL during the MT, particularly during early MT, occur mostly at the right tail, reflecting a greater propensity for longer menstrual cycles, not a lengthening of the median MCL. Greater variability of the longest menstrual cycles is observed during the 2 years before the FMP. Chinese, Japanese, year. FMP is at time 0. Estimated cycle lengths are for women who were white, were normal-weight or underweight, did not smoke, had at least some postYhigh school education, and did not have any moderate or physical activity during the average week. Sample size decreases as time moves farther from the FMP. and obese women, as well as women who begin their transition at older ages, experience consistently longer MCLs throughout the MT. Women with longer mean menstrual cycles during their reproductive years have been shown to have later age at menopause, and women with shorter mean MCLs have demonstrated an earlier age at menopause. 35 These results help explain the variability in women's reports of their transition experience and may help women and clinicians better predict the types of MCL changes that they are likely to experience during the MT. Further investigation into the relationship between MCL in the transition period and duration of early and late MT may facilitate the prediction of expected age at FMP. Because little is known about the transition experience of women with polycystic ovarian syndrome, investigation of MCL patterns among women with this condition is warranted.
